- US12139546utility2024Methods of Treating Urea Cycle Disorders by Interfering with Glucagon Receptor Signaling0 cites
- US12134631utility2024Hydrophilic Linkers for Antibody Drug Conjugates0 cites
- US12135328utility2024Tandem Mass Tag Multiplexed Quantitation of Post-translational Modifications of Proteins0 cites
- US12135327utility2024Systems and Methods for Identifying Hla-associated Tumor Peptides0 cites
- US12127537utility2024Genetically Modified Non-human Animals and Methods of Use Thereof0 cites
- US12127536utility2024Humanized M-CSF Mice0 cites
- US12123879utility2024Heavy Peptide Approach to Accurately Measure Unprocessed C-terminal Lysine0 cites
- USD1047700design2024Packaging0 cites
- US12123001utility2024Methods of Treating Liver Diseases with Phosphodiesterase 3B (PDE3B) Inhibitors0 cites
- US12115216utility2024Anti-human Papillomavirus (HPV) Antigen-binding Proteins and Methods of Use Thereof0 cites
- US12117452utility2024Identification of Host Cell Proteins0 cites
- US12110502utility2024Models of Tauopathy0 cites
- US12103960utility2024VEGF Traps and Mini-traps and Methods for Treating Ocular Disorders and Cancer0 cites
- US12096754utility2024Non-human Animals Having a Humanized Lymphocyte-activation Gene 30 cites
- US12099042utility2024Use of Liquid Chromatography and Mass Spectrometry to Characterize Oligonucleotides0 cites
- US12090201utility2024Methods for Treating Atopic Dermatitis by Administering an IL-4R Antagonist Antibody0 cites
- US12091460utility2024Use of Bispecific Antigen-binding Molecules That Bind MUC16 and CD3 in Combination with 4-1BB Co-stimulation0 cites
- US12091449utility2024Anti-pfrh5 Antibodies and Antigen-binding Fragments Thereof0 cites
- US12091440utility2024IL2 and Peptide-mhc Complex Fusion Proteins and Methods of Use Thereof0 cites